The futures traded higher Thursday morning as investors continue to try and discern exactly what the Democrats’ impeachment plans are. The market had a strong reversal yesterday after President Trump released the transcripts of his phone call with Ukraine President Volodymyr Zelensky. This is a time when investors need to be considering exactly how they want their portfolios and assets positioned for the final months of 2019 and beyond.
24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new ideas for traders and long-term investors alike. Some of the daily analyst calls cover stocks to buy. Other calls cover stocks to sell or to avoid.
We have provided these calls in a quick-hit summary for easy reading, and additional comments and trading data have been added on some of the calls. The consensus analyst price targets and other valuation metrics are from the Refinitiv (Thomson Reuters) sell-side research service.
These are the top analyst upgrades, downgrades and initiations on Thursday, September 26, 2019.
Aarons Inc. (NYSE: AAN) was started with a Buy rating and a $75 price target at Merrill Lynch. The Wall Street consensus price target for the rent-to-own giant is $72.44. The stock was last seen Wednesday trading at $61.63 per share.
AbbVie Inc. (NYSE: ABBV) was raised to Buy from Neutral at Citigroup, which also raised the price target on the pharmaceutical giant to $90. That compares with a consensus target of $86.47. The stock closed Wednesday at $72.09.
Boston Beer Co. Inc. (NYSE: SAM) was raised to Outperform from Market Perform at BMO Capital, which also raised the price target on the stock to $415. The consensus figure for the brewer of specialty beer is $364.58. The stock closed Wednesday at $349.
Bruker Corp. (NASDAQ: BRKR) was raised to Buy from Neutral at Merrill Lynch, which as a price target of $52. That compares with a consensus target of $50.73. The stock ended trading Wednesday at $43.27.
CF Industries Holdings Inc. (NYSE: CF) saw its target price raised to $62 from $59 at Cowen, which also reiterated its Outperform rating on the shares. That compares to the $54.65 consensus target. Shares were last seen trading at $48.67.
Carvana Co. (NASDAQ: CVNA) was started with a Neutral rating and a $75 price target at JPMorgan. The posted consensus price objective is $75.71. The last trade on Wednesday came in at $70.52.
Celanese Corp. (NYSE: CE) was started with an Underperform rating and a $110 price target at Merrill Lynch. The consensus target is higher at $119.95. With the shares closing trading at $122.21, and up almost 40% this year, this could be a valuation call.
Columbia Sportswear Co. (NASDAQ: COLM) was named as the Bull of the Day at Zacks, which said that the outlook appears strong heading into the holiday season. Shares most recently closed at $97.31, with a consensus price target of $119.46.
Denali Therapeutics Inc. (NASDAQ: DNLI) was started with a Neutral rating and a $19 price target at Wedbush. The much higher consensus target is $27.33, and the shares ended trading on Wednesday at $17.32.
Eastman Chemical Co. (NYSE: EMN) was started with a Buy rating and a price target of $84 at Merrill Lynch. The consensus figure is $86.67. The last trade on Wednesday came in at $72.67, with the stock up 2.5% on the day.